{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:45:29Z","timestamp":1790192729751,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.eururo.2014.08.061","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T03:30:53Z","timestamp":1410319853000},"page":"273-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both"],"prefix":"10.1016","volume":"67","author":[{"given":"Stephanie L.","family":"Jarosek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Virnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.08.061_bib0140","unstructured":"National Cancer Institute. SEER Stat fact sheets: prostate cancer. 2012. SEER Web site. http:\/\/seer.cancer.gov\/statfacts\/html\/prost.html."},{"key":"10.1016\/j.eururo.2014.08.061_bib0010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3322\/caac.21149","article-title":"Cancer treatment and survivorship statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2014.08.061_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.juro.2007.03.126","article-title":"Incidence of urethral stricture after primary treatment for prostate cancer: data from CaPSURE","volume":"178","author":"Elliott","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.juro.2012.08.091","article-title":"Severe genitourinary toxicity following radiation therapy for prostate cancer\u2014how long does it last?","volume":"189","author":"Kim","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1748-717X-8-25","article-title":"Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy","volume":"8","author":"Tanaka","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0030","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.eururo.2013.08.013","article-title":"Early salvage radiotherapy following radical prostatectomy","volume":"65","author":"Pfister","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0035","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2014.08.061_bib0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/cncr.20446","article-title":"Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy","volume":"101","author":"Sarosdy","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.08.061_bib0045","series-title":"Comparative effectiveness of therapies for clinically localized prostate cancer. Comparative Effectiveness Review No. 13","author":"Wilt","year":"2008"},{"issue":"Suppl IV","key":"10.1016\/j.eururo.2014.08.061_bib0155","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2014.08.061_bib0055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0150","unstructured":"National Cancer Institute. Common terminology criteria for adverse events (CTCAE) version 4.0 (v4.03: June 14, 2010). Washington, DC: US Department of Health and Human Services; 2011."},{"key":"10.1016\/j.eururo.2014.08.061_bib0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","article-title":"Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study","volume":"15","author":"Nam","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0070","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1200\/JCO.2006.07.9954","article-title":"Patient and treatment factors associated with complications after prostate brachytherapy","volume":"24","author":"Chen","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0075","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/aje\/kwn164","article-title":"Constructing inverse probability weights for marginal structural models","volume":"168","author":"Cole","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.eururo.2014.08.061_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/0962280210386207","article-title":"Diagnosing and responding to violations in the positivity assumption","volume":"21","author":"Petersen","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.eururo.2014.08.061_bib0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.eururo.2014.08.061_bib0095","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med."},{"key":"10.1016\/j.eururo.2014.08.061_bib0100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.eururo.2014.08.061_bib0105","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.juro.2006.07.152","article-title":"Management of severe urethral complications of prostate cancer therapy","volume":"176","author":"Elliott","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0110","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/j.juro.2007.07.028","article-title":"Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection","volume":"178","author":"Peddada","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.08.061_bib0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.brachy.2011.08.006","article-title":"Two-step transurethral surgery of the prostate and permanent implant brachytherapy for patients with lower urinary tract symptoms and low- to intermediate-risk prostate cancer","volume":"11","author":"Ivanowicz","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.eururo.2014.08.061_bib0120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.urology.2013.02.071","article-title":"Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy","volume":"82","author":"Sewell","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2014.08.061_bib0125","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMsa011788","article-title":"Variations in morbidity after radical prostatectomy","volume":"346","author":"Begg","year":"2002","journal-title":"N Engl J Med."},{"issue":"Suppl IV","key":"10.1016\/j.eururo.2014.08.061_bib0160","article-title":"Measuring complications of cancer treatment using the SEER-Medicare data","volume":"40","author":"Potosky","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2014.08.061_bib0135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semradonc.2013.01.004","article-title":"Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer","volume":"23","author":"Pearlstein","year":"2013","journal-title":"Semin Radiat Oncol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814008161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814008161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T19:22:15Z","timestamp":1538248935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814008161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0302283814008161"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.061","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propensity-weighted Long-term Risk of Urinary Adverse Events After Prostate Cancer Surgery, Radiation, or Both","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}